Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
01/06/2005 | WO2005000042A1 Composition containing lactic acid bacterium producing equol |
01/06/2005 | WO2005000034A2 Lactic bacteria and its use in direct-fed microbials |
01/06/2005 | WO2005000032A1 Method for treatment of sores and lesions of the skin |
01/06/2005 | WO2004104491A3 Percussively ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
01/06/2005 | WO2004098285A3 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method |
01/06/2005 | WO2004093890A8 Pharmaceutical composition comprising bioelement (enzyme and factor) |
01/06/2005 | WO2004080175B1 Scaffold for cell growth and differentiation |
01/06/2005 | WO2003041654A3 Anti-estrogen and immune modulator combinations for treating breast cancer |
01/06/2005 | WO2002074234A3 Method and composition for treatment of skeletal dysplasias |
01/06/2005 | US20050005312 Propagation of human hepatocytes in non-human animals |
01/06/2005 | US20050004428 Cardiac disease treatment and device |
01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
01/06/2005 | US20050004037 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
01/06/2005 | US20050004036 Using angiotensin peptides; therapy for ulcer caused by allergens, human immunodeficiency virus, herpes virus infections; stresses; traumas |
01/06/2005 | US20050004006 Using transferrins as tool in reducing concentration of serum glucose, blood pressure, obesity or glycosylated hemoglobins; antidiabetic agents |
01/06/2005 | US20050003537 Composition and method for production of transformed cells |
01/06/2005 | US20050003531 Isolating and generating postmitotic neurons from embryonic spinal cord tissue that are capable of multiple neuronal phenotypes for use in treatment and prevention of nervous system disorders |
01/06/2005 | US20050003529 Stem cells and method of separating the same |
01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
01/06/2005 | US20050003472 Process for the staining of sperm |
01/06/2005 | US20050003460 Identifying progenitor cell populations comprising at least one disaccharide repeat of glucuronic acid and n-acetylglucosamine and enhanced hyaluronic acid synthase expression for use in tissue repair and treatment and prevention of cancer and/or skin disorders. |
01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
01/06/2005 | US20050003431 Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor |
01/06/2005 | US20050003017 Hypotensive and hypertensive properties of renomedullar extracts |
01/06/2005 | US20050002988 Nutritional composition for controlling blood sugar level |
01/06/2005 | US20050002949 Prevention and treatment of irritable bowel syndrome |
01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
01/06/2005 | US20050002921 Containing lactococcus lactis, lactobacillus lactis and/or lactobacillus brevis; reducing diaherrea, improving performance; healthy dairy calves |
01/06/2005 | US20050002920 Collecting, activating, culturing and optionally expanding peripheral blood mononuclear cells then hypomethylating with 5-aza-cytidine or 5-aza-2'-deoxycytidine |
01/06/2005 | US20050002919 Using modified cells for drug, diagnostic agent and/or toxin delivery to target tissues; novel genetically altered human progenitor cells |
01/06/2005 | US20050002915 Enhancement of angiogenesis to grafts using cells engineered to produce growth factors |
01/06/2005 | US20050002914 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
01/06/2005 | US20050002909 Methods and compositions for treating intervertebral disc degeneration |
01/06/2005 | US20050002908 Method for producing a recombinant adeno-associated virus, suitable means therefor and use for producing a medicament |
01/06/2005 | US20050002906 Preferentially amplifying in tumors following cancer cell activation of specific gene regulatory region |
01/06/2005 | US20050002904 Uses of vascular endothelial growth factor and type I collagen inducible protein (VCIP) |
01/06/2005 | US20050002884 Essential oil, petroleum jelly, lecithin and water; repairing damage; soft feel, lustrous appearance |
01/06/2005 | US20050002874 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
01/06/2005 | CA2531058A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
01/06/2005 | CA2531017A1 Composition for external use |
01/06/2005 | CA2530631A1 Use of bacilli-class bacteria to produce a composition for the prevention of vertebral compression syndrome in salmonids |
01/06/2005 | CA2530422A1 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system |
01/06/2005 | CA2530255A1 Soft tissue repair and regeneration using postpartum-derived cells |
01/06/2005 | CA2529943A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
01/06/2005 | CA2529941A1 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
01/06/2005 | CA2529143A1 Methods of producing neurons |
01/06/2005 | CA2525596A1 Allogeneic cell therapy: mirror effect |
01/05/2005 | EP1493459A1 System and method for separation of particles |
01/05/2005 | EP1493444A1 Pharmaceutical composition used as anti-infective of the upper respiratory tract |
01/05/2005 | EP1493432A1 In vivo method of obtaining cell components |
01/05/2005 | EP1492869A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
01/05/2005 | EP1492868A2 Method of modulating inflammatory response |
01/05/2005 | EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
01/05/2005 | EP1492565A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
01/05/2005 | EP1492549A1 Compositions and methods for augmenting kidney function |
01/05/2005 | EP1492415A2 Method of improving absorption of vitamin e by a pet animal |
01/05/2005 | EP1492414A2 Method and dietary composition for improving fat digestibility |
01/05/2005 | EP1492413A2 Method and dietary composition for improving lipid digestibility |
01/05/2005 | EP1423504A4 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
01/05/2005 | EP1393067A4 Encapsulated cell indicator system |
01/05/2005 | EP1290141A4 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway |
01/05/2005 | EP1152773B1 Methods of inactivating pathogens using broad-spectrum pulsed light |
01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
01/05/2005 | DE10329839A1 Use of artificial nutrition solutions to treat skin diseases, especially psoriasis, neurodermatitis, acne, dermatoses or eczema |
01/05/2005 | DE10326187A1 Zellen als Träger für Bakterien Cells as carriers for bacteria |
01/05/2005 | CN1561388A Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications |
01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
01/05/2005 | CN1561232A Therapeutic agent comprising a B-subunit of a protein toxin |
01/05/2005 | CN1561231A Inhibition of neonatal hyperbilirubinemia in breast fed infants |
01/05/2005 | CN1561221A Novel medicinal herbal composition for treating liver diseases and HIV |
01/05/2005 | CN1561217A Estrogen/gestagen combination preparation and application thereof |
01/05/2005 | CN1561206A Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction |
01/05/2005 | CN1561197A Method for producing biologically active products |
01/05/2005 | CN1560261A Production process of whole silkworm chrysalis powder containing lactoferrbumin and its peptide |
01/05/2005 | CN1560080A Corpuscles of stannius protein, stanniocalcin |
01/05/2005 | CN1559495A Deer's fetus granular Chinese madicinal preparation and its production technology |
01/05/2005 | CN1559449A Method for preparing oral liquid for treating prematophagoides farnae |
01/05/2005 | CN1559448A Traditional Chinese medicine for treating tuberculosis, and its prepn. method |
01/05/2005 | CN1559447A Extracte of Aspongopus chinensis Dallas and Extraction method therefor medicinal use and preparn. thereof |
01/05/2005 | CN1559446A Antimicrobial (tincture)medicine with functons of analgesia, hemostasis and relieving-itching |
01/05/2005 | CN1559445A Antimicrobial (aqua)medicine with functions of analgesia, hemostasis and reliveing-itching |
01/05/2005 | CN1559444A Oral liquid contg. extration of sturgeon and sturgeon active protein capsule, prepn. method therefor |
01/05/2005 | CN1559443A Sturgeon chondroition capsule and instant granula prepn. method therefor |
01/05/2005 | CN1559442A Soft capsule of dried oviduct fat of forest frog |
01/05/2005 | CN1559441A Method for preparing immune milk anti-pathogenic microoganism in digestive tract |
01/05/2005 | CN1559440A Low-temp freezing method for storing sperm of gayal |
01/05/2005 | CN1183250C Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis nihibitory factor and its construction method |
01/05/2005 | CN1183247C Membrane destroyed freeze-bried spermatozoa or sperm head and its making method |
01/05/2005 | CN1183157C Method for distillig active protein liquid of scorpion |
01/05/2005 | CN1182863C Chinese herbal medicine for enhancing immunity |
01/05/2005 | CN1182859C Externally applied Chinese medicine for treating trauma and its prepn. |
01/04/2005 | US6838446 Anticancer agents; genetic engineered enzyme |
01/04/2005 | US6838444 Using nucleic acid; repair interior ear hair |
01/04/2005 | US6838428 A non-human mammal phenotype, vectors expressing the protein for treating respiratory system disease, viral diseases, purifying SP-D antibodies, enzyme inhibitor of metalloproteinase |
01/04/2005 | US6838281 Cells expressing fusion proteins of immunoglobulins |
01/04/2005 | US6838084 For connection with major histomcompatability complex molecules |
01/04/2005 | CA2332406C Treatment of neuromuscular disorders and conditions with different botulinum serotype |
01/04/2005 | CA2217322C Inhibition of complement pathway by sea cucumber fractions |
12/30/2004 | US20040268424 tissues, organs and cells for use in xenotransplantation |